Press Releases Hikma Pharmaceuticals PLC

Equities

HIK

GB00B0LCW083

Market Closed - London S.E. Other stock markets 11:35:19 2024-05-03 EDT			5-day change	1st Jan Change
1,960 ^GBX	+1.82%		+2.46%	+9.56%

05-03	Deutsche Bank Starts Hikma Pharmaceuticals Coverage at Buy	MT
05-03	Jefferies cuts AJ Bell; Deutsche likes ConvaTec	AN

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Hikma Pharmaceuticals : Special Business passed at AGM	04-25	PU
Hikma appoints Dr. Hafrun Fridriksdottir as President of Generics business	04-16	AQ
Hikma launches Fentanyl Citrate Injection, USP, in a prefilled syringe in the US	02-21	AQ
Hikma Pharmaceuticals PLC - Notice of preliminary results	02-06	AQ
Activ Surgical, a Hikma Ventures portfolio company, completes the first international procedure using ActivSight Intelligent Light at Abdali Hospital in Jordan	01-24	AQ
Activ Surgical Announces Completion of First International Procedure Using Its ActivSight Intelligent Light	01-23	AQ
Guardant Health and Hikma Partner to Offer Cancer Screening and Comprehensive Genomic Profiling Tests in the Middle East and North Africa	01-08	BU
Hikma launches Phenylephrine HCl Injection, USP, in ready-to-use vials in the US	12-20	AQ
Hikma continues strong momentum across the Group and upgrades guidance for 2023	11-03	AQ
Hikma and CanariaBio sign exclusive licensing agreement to bring Oregovomab to the Middle East and North Africa	23-10-11	AQ
Hikma marks two-year anniversary of KLOXXADO launch by surpassing 375,000 doses donated in the US	23-10-04	AQ
Hikma and SK Biopharmaceuticals enter a strategic partnership for the Middle East and North Africa	23-08-21	AQ
Hikma remains a constituent of the FTSE4Good Index	23-08-16	AQ
Hikma and Rakuten Medical sign exclusive licensing agreement for Alluminox platform cancer treatment for the Middle East and North Africa	23-08-11	AQ
Hikma appoints new President of Injectables business	23-08-10	AQ
Hikma Ventures invests in Octave Bioscience, a precision care platform for Multiple Sclerosis and other neurodegenerative diseases	23-07-27	AQ
Octave Bioscience Closes $30M Extension to Series B Funding	23-07-27	AQ
Hikma Pharmaceuticals PLC - Notice of results	23-07-18	AQ
Hikma launches Midazolam in 0.9% Sodium Chloride Injection in the US	23-07-03	AQ
Hikma launches Neostigmine Methylsulfate Injection, USP in prefilled syringe	23-06-16	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

HIKMA PHARMACEUTICALS : Hikma’s Q1 progress appreciated by the markets

April 26, 2024 at 06:50 am